MEIS1 & VASCULAR MK

Role of Meis1 in the embryonic megakaryocyte lineage and vascular development

 Coordinatore FUNDACION CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III 

 Organization address address: C/ MELCHOR FERNANDEZ ALMAGRO 3
city: MADRID
postcode: 28029

contact info
Titolo: Dr.
Nome: Miguel
Cognome: Torres
Email: send email
Telefono: -4531335
Fax: -4531361

 Nazionalità Coordinatore Spain [ES]
 Totale costo 153˙917 €
 EC contributo 153˙917 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2009-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-06-01   -   2012-05-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    FUNDACION CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III

 Organization address address: C/ MELCHOR FERNANDEZ ALMAGRO 3
city: MADRID
postcode: 28029

contact info
Titolo: Dr.
Nome: Miguel
Cognome: Torres
Email: send email
Telefono: -4531335
Fax: -4531361

ES (MADRID) coordinator 153˙917.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

cellular    lack    first    interaction    embryonic    mutant    lineage    vascularization    vasculature    null    description    functional    mice    megakaryocytes    endothelium    megakaryocyte    vascular    embryos    defects    meis    haematopoietic    function    megakaryocytic   

 Obiettivo del progetto (Objective)

'The main aim of the present project is to provide the first description of embryonic megakaryocyte function during vascular development and maintenance. The recent description of embryonic megakaryocytes existence together with the presence of vascular defects in all mouse mutant models that lack embryonic megakaryocytes suggests that a cellular interaction between embryonic megakaryocytes and endothelium is essential for the correct patterning and stability of the vasculature. The vascular system is the first organ to become functional in the embryo and its regulatory mechanisms are of ultimate medical importance in cancer, development, homeostasis, healing and regeneration. Likewise, blood and endothelium develop in close association and it is surprising to realize how little we know on how specific haematopoietic lineages support the development of a functional vasculature. We will address this important issue by characterizing the function of Meis1 in the megakaryocytic lineage and of the megakaryocytic lineage in vascularization. Meis1 mutant mice are the only known mutant mice that lack embryonic megakaryocytes without another apparent haematopoietic deficiency. Therefore, Meis1 null mice present a unique opportunity to investigate this common denominator – absence of megakaryocytes – on all haematopoietic mutants that present vascular defects. We will achieve this goal by: 1) a detailed characterization of the Meis1 vascular defect using histological approaches and optical projection tomography; 2) imaging the behaviour and interaction of the megakaryocyte cellular equivalents and the endothelium in live zebrafish embryos; and 3) establish the role of Meis1 and of embryonic megakaryocytes in embryonic vascularization through the targeted elimination of this lineage, the rescue of Meis1 null vascular phenotype by megakaryocyte progenitor transplantation and by the conditional reactivation of Meis function in the megakaryocytic lineage of Meis1 null embryos.'

Altri progetti dello stesso programma (FP7-PEOPLE)

SEASONS (2014)

UNDERSTANDING THE IMPACT OF SEASONALITY IN TERRESTRIAL BIO-GEOSYSTEMS DURING THE LAST 23 MILLION YEARS

Read More  

PHIL-RISK (2009)

Philosophy of Risk: An evaluative account of risk and safety and the methodological consequences for risk research

Read More  

ERTMABTU (2010)

Experimental Radiotherapy for Malignant Brain Tumours

Read More